Eiron Cudaback

1.2k total citations
22 papers, 812 citations indexed

About

Eiron Cudaback is a scholar working on Physiology, Neurology and Pharmacology. According to data from OpenAlex, Eiron Cudaback has authored 22 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 11 papers in Neurology and 8 papers in Pharmacology. Recurrent topics in Eiron Cudaback's work include Alzheimer's disease research and treatments (12 papers), Neuroinflammation and Neurodegeneration Mechanisms (11 papers) and Cannabis and Cannabinoid Research (5 papers). Eiron Cudaback is often cited by papers focused on Alzheimer's disease research and treatments (12 papers), Neuroinflammation and Neurodegeneration Mechanisms (11 papers) and Cannabis and Cannabinoid Research (5 papers). Eiron Cudaback collaborates with scholars based in United States, Japan and Germany. Eiron Cudaback's co-authors include C. Dirk Keene, Thomas J. Montine, Nephi Stella, Kathleen S. Montine, Xianwu Li, Yue Yang, William Marrs, José A. Cisneros, Didier M. Lambert and Giulio G. Muccioli and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Eiron Cudaback

22 papers receiving 801 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eiron Cudaback United States 15 345 251 207 201 199 22 812
Irene Sánchez-Vera Spain 9 304 0.9× 103 0.4× 210 1.0× 296 1.5× 294 1.5× 9 914
Andreu Viader United States 13 267 0.8× 210 0.8× 415 2.0× 499 2.5× 83 0.4× 18 1.2k
Annett Häußler Germany 23 197 0.6× 374 1.5× 369 1.8× 248 1.2× 93 0.5× 33 1.1k
Alexander I. Bondarenko Austria 20 209 0.6× 209 0.8× 608 2.9× 290 1.4× 79 0.4× 46 1.0k
Victor Howard United States 11 118 0.3× 468 1.9× 232 1.1× 169 0.8× 337 1.7× 16 906
David Dávila Spain 13 209 0.6× 100 0.4× 383 1.9× 145 0.7× 60 0.3× 19 804
Margarita Suardíaz Spain 12 240 0.7× 143 0.6× 174 0.8× 160 0.8× 47 0.2× 17 591
Ovidiu Coste Germany 17 258 0.7× 330 1.3× 294 1.4× 184 0.9× 41 0.2× 25 819
Nathaniel S. Woodling United States 19 243 0.7× 476 1.9× 551 2.7× 207 1.0× 386 1.9× 32 1.4k
Joliet Bembry United States 12 206 0.6× 112 0.4× 226 1.1× 176 0.9× 101 0.5× 13 614

Countries citing papers authored by Eiron Cudaback

Since Specialization
Citations

This map shows the geographic impact of Eiron Cudaback's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiron Cudaback with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiron Cudaback more than expected).

Fields of papers citing papers by Eiron Cudaback

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eiron Cudaback. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiron Cudaback. The network helps show where Eiron Cudaback may publish in the future.

Co-authorship network of co-authors of Eiron Cudaback

This figure shows the co-authorship network connecting the top 25 collaborators of Eiron Cudaback. A scholar is included among the top collaborators of Eiron Cudaback based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eiron Cudaback. Eiron Cudaback is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cudaback, Eiron & David Graykowski. (2021). Don’t know what you got till it’s gone: microglial depletion and neurodegeneration. Neural Regeneration Research. 16(10). 1921–1921. 12 indexed citations
2.
Graykowski, David, et al.. (2020). Neuroinflammation drives APOE genotype-dependent differential expression of neprilysin. Journal of Neuroimmunology. 346. 577315–577315. 6 indexed citations
3.
Yang, Yue, C. Dirk Keene, Elaine R. Peskind, et al.. (2015). Cerebrospinal Fluid Particles in Alzheimer Disease and Parkinson Disease. Journal of Neuropathology & Experimental Neurology. 74(7). 672–687. 31 indexed citations
4.
Wang, David B., Yoshito Kinoshita, C. Kinoshita, et al.. (2015). Loss of endophilin-B1 exacerbates Alzheimer’s disease pathology. Brain. 138(7). 2005–2019. 28 indexed citations
5.
Cudaback, Eiron, Yue Yang, Thomas J. Montine, & C. Dirk Keene. (2014). APOEgenotype-dependent modulation of astrocyte chemokine CCL3 production. Glia. 63(1). 51–65. 34 indexed citations
6.
Sexton, Michelle, Eiron Cudaback, Rehab A. Abdullah, et al.. (2014). Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters. Inflammopharmacology. 22(5). 295–303. 23 indexed citations
7.
Yang, Yue, et al.. (2014). Wild-type bone marrow transplant partially reverses neuroinflammation in progranulin-deficient mice. Laboratory Investigation. 94(11). 1224–1236. 4 indexed citations
8.
Cudaback, Eiron, Nikolas L. Jorstad, Yue Yang, Thomas J. Montine, & C. Dirk Keene. (2014). Therapeutic implications of the prostaglandin pathway in Alzheimer's disease. Biochemical Pharmacology. 88(4). 565–572. 49 indexed citations
9.
Yang, Yue, Eiron Cudaback, Nikolas L. Jorstad, et al.. (2013). APOE3, but Not APOE4, Bone Marrow Transplantation Mitigates Behavioral and Pathological Changes in a Mouse Model of Alzheimer Disease. American Journal Of Pathology. 183(3). 905–917. 26 indexed citations
10.
Yu, Chang-En, Eiron Cudaback, Jessica Foraker, et al.. (2013). Epigenetic signature and enhancer activity of the human APOE gene. Human Molecular Genetics. 22(24). 5036–5047. 53 indexed citations
11.
Cudaback, Eiron, Xianwu Li, Kathleen S. Montine, et al.. (2012). Apolipoprotein C-I is an APOE genotype-dependent suppressor of glial activation. Journal of Neuroinflammation. 9(1). 192–192. 38 indexed citations
12.
Li, Xianwu, Eiron Cudaback, Richard Breyer, et al.. (2012). Eicosanoid receptor subtype‐mediated opposing regulation of TLR‐stimulated expression of astrocyte glial‐derived neurotrophic factor. The FASEB Journal. 26(7). 3075–3083. 14 indexed citations
13.
Li, Xianwu, Eiron Cudaback, C. Dirk Keene, Richard Breyer, & Thomas J. Montine. (2011). Suppressed microglial E prostanoid receptor 1 signaling selectively reduces tumor necrosis factor alpha and interleukin 6 secretion from toll‐like receptor 3 activation. Glia. 59(4). 569–576. 16 indexed citations
14.
Keene, C. Dirk, Eiron Cudaback, Xianwu Li, Kathleen S. Montine, & Thomas J. Montine. (2011). Apolipoprotein E isoforms and regulation of the innate immune response in brain of patients with Alzheimer's disease. Current Opinion in Neurobiology. 21(6). 920–928. 75 indexed citations
15.
Cudaback, Eiron, Xianwu Li, Kathleen S. Montine, Thomas J. Montine, & C. Dirk Keene. (2011). Apolipoprotein E isoform‐dependent microglia migration. The FASEB Journal. 25(6). 2082–2091. 39 indexed citations
16.
Cudaback, Eiron, et al.. (2010). The Expression Level of CB1 and CB2 Receptors Determines Their Efficacy at Inducing Apoptosis in Astrocytomas. PLoS ONE. 5(1). e8702–e8702. 70 indexed citations
17.
Sexton, Michelle, Grace Woodruff, Eiron Cudaback, et al.. (2009). Binding of NIR-conPK and NIR-6T to Astrocytomas and Microglial Cells: Evidence for a Protein Related to TSPO. PLoS ONE. 4(12). e8271–e8271. 8 indexed citations
18.
Muccioli, Giulio G., Cong Xu, Eiron Cudaback, et al.. (2007). Identification of a Novel Endocannabinoid-Hydrolyzing Enzyme Expressed by Microglial Cells. Journal of Neuroscience. 27(11). 2883–2889. 144 indexed citations
19.
Cudaback, Eiron & Nephi Stella. (2007). Targeting Astrocytomas and Invading Immune Cells with Cannabinoids: A Promising Therapeutic Avenue. Molecular Neurobiology. 36(1). 36–44. 6 indexed citations
20.
Misra-Press, A., Michael McMillan, Eiron Cudaback, et al.. (2002). Identification of a Novel Inhibitor of the NF-κB Pathway. 1(1). 29–39. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Irene Sánchez-Vera Breakdown of academic impact, for papers by Andreu Viader Breakdown of academic impact, for papers by Annett Häußler Breakdown of academic impact, for papers by Alexander I. Bondarenko Breakdown of academic impact, for papers by Victor Howard Breakdown of academic impact, for papers by David Dávila Breakdown of academic impact, for papers by Margarita Suardíaz Breakdown of academic impact, for papers by Ovidiu Coste Breakdown of academic impact, for papers by Nathaniel S. Woodling Breakdown of academic impact, for papers by Joliet Bembry
Rankless by CCL
2026